Previous bioinformatic analyses showed that hsa-miR-30d-3p was associated with non-small cell lung cancer and inhibited epidermal growth factor receptor-targeted medicine therapy (Wang et al., 2017; Pan et al., 2019). Here, EGFR is linked to non-small cell lung carcinoma.